TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
LIVN

LivaNova PLC

Healthcare · Medical Devices

77.20$ -1.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

LivaNova PLC (LIVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 254 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow LIVN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-12 -15 -15 -8.2 – -23 1.3 3.6 -4.0 -71 -21 14 25 43 50 75 79 54 54 80 90 91 121 -91 -79 103 70 75 183 254
0.3 0.7 1.5 1.4 – 4.3 5.1 4.9 4.0 4.5 4.5 4.0 2.2 2.2 2.7 4.7 4.6 5.6 5.6 7.3 85 83 70 83 81 68 58 61 51 42
– – – – – – – – – – – 0.2 9.7 8.6 11 12 11 11 46 46 20 19 27 33 35 41 45 36 34 36
– – – – – – – – – – – – – – – – – 4.7 21 34 90 150 -81 168 261 124 109 – – –
-1.0 -1.4 -3.9 -5.7 – -1.3 -8.3 -8.4 4.3 -16 6.5 9.7 -2.6 -0.7 -4.4 0.2 -7.4 -11 -11 -6.3 -21 -89 4.8 -62 -111 29 -32 -35 1.3 370
0.3 3.5 1.7 4.1 3.6 5.1 4.2 2.6 3.7 4.3 1.4 0.8 2.7 6.1 7.4 18 14 19 19 6.7 37 34 38 25 35 25 27 35 47 81
-7.5 -35 13 -1.6 0.1 -3.3 -4.2 -2.6 -12 18 -1.4 -0.8 -2.9 -6.2 -11 -22 -36 -34 -34 -9.8 -38 -53 -121 -41 -42 37 -38 -40 -48 -73
– – – – – – – – – – – – – 43 – – – – – – 0.0 0.0 – 4.8 – – – – – –
– – – – – – – – -10.0 -10.0 -6.3 -0.5 -1.7 -14 -50 -33 -72 -55 -55 -55 -55 -4.1 -62 -7.1 -5.6 -13 -8.7 -7.5 -8.4 -4.4
– – – – – – – – – – – – – – – – – -31 -31 -31 -48 12 60 172 339 -488 284 28 88 -281
18 50 1.4 8.0 45 9.1 8.2 14 11 107 14 -7.4 -47 -44 -7.2 -47 -19 -37 -37 -48 -124 11 -42 147 311 -181 280 21 19 -286
-1.4 0.9 -0.1 -1.8 – -17 5.4 15 -4.8 54 -7.6 6.3 -25 -7.0 30 7.3 24 -17 -17 21 -73 54 -46 14 192 -45 308 62 146 -88
-12 -18 -16 -12 – -28 -2.9 1.0 -7.7 -75 -22 14 22 37 42 57 65 35 35 73 53 57 83 -116 -114 77 43 40 136 173

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?